Mona Wilcke

Mona Wilcke is the current advisor at Empe Diagnostics. Mona has previously worked as senior investment manager at Sätila Medtech AB, founder and CEO at Glucox Biotech AB, CEO at Evitra Proteoma AB, and group leader for target identification at Accuro Immunology AB. Wilcke began their career as a researcher at Pharmacia before doing a post doc at Institute Curie in Paris, France.

Mona Wilcke has a PhD in Biochemistry and Molecular Biology from Stockholm University.